Description
LXH254 is a type II RAF inhibitor.
| Product Unit Size | Cost | Quantity | Stock |
|---|
LXH254 is a type II RAF inhibitor.
| Cas No. | 1800398-38-2 |
|---|---|
| Purity | ≥99% |
| Formula | C25H25F3N4O4 |
| Formula Wt. | 502.49 |
| IUPAC Name | N-[3-[2-(2-hydroxyethoxy)-6-morpholin-4-ylpyridin-4-yl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide |
| Synonym | Naporafenib |
| Appearance | White powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Monaco K, Delach S, Yuan J, et al. LXH254, a potent and selective ARAF-sparing inhibitor of BRAF and CRAF for the treatment of MAPK-driven tumors. Clin Cancer Res. 2021 Apr 1;27(7):2061-2073. PMID: 33355204
Park S, Kim T, Cho S, et al. Combined blockade of polo-like kinase and pan-RAF is effective against NRAS-mutant non-small cell lung cancer cells. Cancer Lett. 2020 Dec 28;495:135-144. PMID: 32979462
TRPC5 activator, NS4B and histamine H1 inhibito...
Flavonol found in Tagetes.
Triazole; 14-α demethylase inhibitor, potentia...
Phthalide; PPARγ agonist, IMPDH inhibitor, mic...
Quinolone, antioxidant.
Statin; HMG-CoA reductase inhibitor, potential ...
Endogenous APP peptide cleavage product, primar...
Tetracycline; protein translation inhibitor.
D2 and 5-HT2A antagonist.
R-type Ca2+ and voltage-gated Na+ channel block...
Synthetic derivative of selenocyanate.
Antioxidative food and cosmetics additive.
Endogenous tachykinin peptide, involved in infl...
Fetal hemoglobin stimulator; ribonucleotide red...
Fluoroquinolone; topoisomerase IV and bacterial...
PI3K and mTOR inhibitor.
Anthraquinone found in various plant sources.
Protein translation inhibitor.
BRD2/4/9 and CECR2 inhibitor.
Thioamide; thyroid peroxidase inhibitor.